Moderna, Inc. ( NASDAQ: MRNA) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan ...

Summit Therapeutics' latest HARMONi trial data shows PFS benefit, but overall survival improvement remains unclear. Click ...

The venture arms of Merck KGaA and Novartis are among the investors involved in raising $67 million for NRG Therapeutics, which aims to bring its first medicine into clinical testing next year.

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 ...

A next-generation cancer immunotherapy by BioNTech and partner Bristol Myers Squibb led to encouraging tumour shrinkage in a ...

Summit Therapeutics Inc.’s shares plummeted after new data cast doubt on the future of its closely-watched lung cancer drug.

According to analysts, the new data could present a path to accelerated approval for ifinatamab deruxtecan, a product of ...

Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor ...

Consultants have a lot to gain helping companies deploy the most transformative technology in decades. Some clients say so far they have overpromised and underdelivered.

The ORR is down slightly from the rate seen in an earlier stage of the trial, in which the B7-H3-directed ADC was tied to a ...

Merck & Co., Inc. (NYSE:MRK) is one of the Most Undervalued S&P 500 Stocks to Buy Right Now. On August 26, Daina Graybosch ...